BioCryst Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
16.70
|
|
Average Rating
|
3.67
|
|
# Strong Buys
|
2
|
|
# Buys
|
4
|
|
# Holds
|
6
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.29
|
-0.23
|
0.06
|
20.69%
|
|
2022-06-30
|
-0.34
|
-0.32
|
0.02
|
5.88%
|
|
2022-03-31
|
-0.37
|
-0.40
|
-0.03
|
-8.11%
|
|
2021-12-31
|
-0.30
|
-0.10
|
0.20
|
66.67%
|
|
2021-09-30
|
-0.29
|
-0.33
|
-0.04
|
-13.79%
|
|
2021-06-30
|
-0.24
|
-0.24
|
0.00
|
0.00%
|
|
2021-03-31
|
-0.27
|
-0.36
|
-0.09
|
-33.33%
|
|
2020-12-31
|
-0.25
|
-0.34
|
-0.09
|
-36.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.95
|
|
2021-12-31
|
-1.03
|
|
2020-12-31
|
-1.08
|
|
2019-12-31
|
-0.98
|
|
2018-12-31
|
-0.98
|
|
2017-12-31
|
-0.78
|
|
2016-12-31
|
-0.75
|
|
2015-12-31
|
-0.60
|
|
2014-12-31
|
-0.68
|
|
2013-12-31
|
-0.55
|
|
2012-12-31
|
-0.75
|
|
2011-12-31
|
-1.26
|
|
2010-12-31
|
-0.73
|
|
2009-12-31
|
-0.40
|
|
2008-12-31
|
-0.65
|
|
2007-12-31
|
-0.92
|
|
2006-12-31
|
-1.49
|
|
2005-12-31
|
-1.02
|
|
2004-12-31
|
-0.99
|
|
2003-12-31
|
-0.71
|
|
2002-12-31
|
-0.96
|
|
2001-12-31
|
-0.42
|
|
2000-12-31
|
-0.21
|
|
1999-12-31
|
-0.36
|
|
1998-12-31
|
-0.34
|
|
1997-12-31
|
-0.44
|
|
1996-12-31
|
-0.69
|
|
1995-12-31
|
-0.98
|
|
1994-12-31
|
-0.71
|